About This Statistic
This statistic represents the top diabetes drugs in the United States, based on revenue between July 2011 and June 2012. In this period, diabetes drug Actos generated around 2.7 billion U.S. dollars of revenues.
The Statistics Portal
Statistics and Studies from more than 18,000 Sources